Intellectual property and funding: fueling Chinese synbio.
Trends Biotechnol
; 42(3): 258-260, 2024 03.
Article
en En
| MEDLINE
| ID: mdl-37980185
As China emerges as a synthetic biology (synbio) global leader, it faces distinct science-society challenges. Our series offers a snapshot of China's synbio state, emphasizing the intersection and its policy implications. The debut piece elucidates the intellectual property rights (IPR)-funding interplay in China's expanding synbio territory, underlining its key role in driving innovation and commercialization.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Propiedad Intelectual
/
Biología Sintética
País/Región como asunto:
Asia
Idioma:
En
Revista:
Trends Biotechnol
Año:
2024
Tipo del documento:
Article
País de afiliación:
China